Market Overview:
The global inflammatory skin diseases treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of inflammatory skin diseases, rising awareness about available treatments, and growing demand for better-quality therapies. The global inflammatory skin diseases treatment market is segmented on the basis of type into retinoids, corticosteroids, calcineurin inhibitors, and others. The corticosteroid segment is expected to account for the largest share of the global market in 2018 owing to its high efficacy and widespread use for treating various types of inflammatory skin diseases. On the basis of application, the hospital pharmacies segment is expected to account for the largest share of the global market in 2018 owing to increased spending by hospitals on drugs and therapies for treating patients with inflammatory skin diseases.
Product Definition:
Inflammatory skin diseases treatment is a type of medical care that is used to help reduce or eliminate the symptoms of inflammatory skin diseases. This type of treatment can include prescription medications, over-the-counter treatments, and/or lifestyle changes. By reducing or eliminating the inflammation associated with these conditions, it may be possible to improve the overall appearance and health of the skin.
Retinoids:
Retinoids are a group of vitamins that help the body's cells to grow and multiply. As we age, the amount of these vitamins in our bodies reduces; thus, when the levels get lower than normal, skin diseases occur. Retinoids play an important role in treating inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis by increasing blood flow to affected areas and removing waste products that cause inflammation.
Corticosteroids:
Corticosteroids are the group of drugs that act as anti-inflammatory agents. Corticosteroid medication is used to reduce inflammation in various parts of the body such as skin, joints, and digestive system. The most commonly used corticosteroid is betamethasone (Decadron). It’s a white crystalline compound derived from cholesterol.
Application Insights:
The acute skin injury segment dominated the market for inflammatory skin diseases treatment and held the largest revenue share in 2017. This is due to a rise in number of burn injuries caused by house fire, road accidents, etc. Acute skin injuries are treated with topical steroids which help reduce inflammation and prevent secondary damage to the deeper layers of the epidermis (dermal layer). The chronic wounds segment is anticipated to witness lucrative growth over the forecast period owing to rising cases of diabetes and obesity worldwide. Chronic or second-degree burns require specialized care as they may lead to permanent scarring if not treated properly. These types Inflammatory Skin Diseases Treatment Market Report include surgical & non-surgical wound care therapies along with medical management such as dressings, bandages, plasters & splints for supporting injured areas that result in significant healing times usually ranging from 2to4weeks post injury depending upon its severity.
Regional Analysis:
North America dominated the global inflammatory skin diseases treatment market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for technologically advanced products are some factors responsible for its large share. Moreover, increasing prevalence of psoriasis in this region is driving the market growth. According to Psoriasis Canada’s survey in 2016, around 2 million people were suffering from psoriasis in North America; however, only 10% of them had received proper diagnosis which resulted into a higher number of undiagnosed cases (31%) (Psoriasis Canada 2016).
Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to rising disposable income resulting into increased spending on healthcare.
Growth Factors:
- Increasing incidence of inflammatory skin diseases
- Growing awareness about available treatment options for inflammatory skin diseases
- Rising demand for better and more effective treatments for inflammatory skin diseases
- Technological advancements in the field of inflammatory skin diseases treatment 5. Availability of government funding and support for research and development activities in the field of inflammatory skin diseases treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Inflammatory Skin Diseases Treatment Market Research Report
By Type
Retinoids, Corticosteroids, Calcineurin Inhibitors, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Pfizer, Merck, AbbVie, Novartis, Boehringer Ingelheim, Amgen, Eli Lilly
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Inflammatory Skin Diseases Treatment Market Report Segments:
The global Inflammatory Skin Diseases Treatment market is segmented on the basis of:
Types
Retinoids, Corticosteroids, Calcineurin Inhibitors, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Merck
- AbbVie
- Novartis
- Boehringer Ingelheim
- Amgen
- Eli Lilly
Highlights of The Inflammatory Skin Diseases Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Retinoids
- Corticosteroids
- Calcineurin Inhibitors
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Inflammatory Skin Diseases Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for inflammatory skin diseases will vary depending on the specific condition. However, some common treatments include topical medications such as corticosteroids or antihistamines, laser therapy or surgery.
Some of the major companies in the inflammatory skin diseases treatment market are Pfizer, Merck, AbbVie, Novartis, Boehringer Ingelheim, Amgen, Eli Lilly.
The inflammatory skin diseases treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Inflammatory Skin Diseases Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Inflammatory Skin Diseases Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Inflammatory Skin Diseases Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Inflammatory Skin Diseases Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Inflammatory Skin Diseases Treatment Market Size & Forecast, 2018-2028
4.5.1 Inflammatory Skin Diseases Treatment Market Size and Y-o-Y Growth
4.5.2 Inflammatory Skin Diseases Treatment Market Absolute $ Opportunity
Chapter 5 Global Inflammatory Skin Diseases Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Inflammatory Skin Diseases Treatment Market Size Forecast by Type
5.2.1 Retinoids
5.2.2 Corticosteroids
5.2.3 Calcineurin Inhibitors
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Inflammatory Skin Diseases Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Inflammatory Skin Diseases Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Inflammatory Skin Diseases Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Inflammatory Skin Diseases Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Inflammatory Skin Diseases Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Inflammatory Skin Diseases Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Inflammatory Skin Diseases Treatment Market Size Forecast by Type
9.6.1 Retinoids
9.6.2 Corticosteroids
9.6.3 Calcineurin Inhibitors
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Inflammatory Skin Diseases Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Inflammatory Skin Diseases Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Inflammatory Skin Diseases Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Inflammatory Skin Diseases Treatment Market Size Forecast by Type
10.6.1 Retinoids
10.6.2 Corticosteroids
10.6.3 Calcineurin Inhibitors
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Inflammatory Skin Diseases Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Inflammatory Skin Diseases Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Inflammatory Skin Diseases Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Inflammatory Skin Diseases Treatment Market Size Forecast by Type
11.6.1 Retinoids
11.6.2 Corticosteroids
11.6.3 Calcineurin Inhibitors
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Inflammatory Skin Diseases Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Inflammatory Skin Diseases Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Inflammatory Skin Diseases Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Inflammatory Skin Diseases Treatment Market Size Forecast by Type
12.6.1 Retinoids
12.6.2 Corticosteroids
12.6.3 Calcineurin Inhibitors
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Inflammatory Skin Diseases Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Inflammatory Skin Diseases Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Inflammatory Skin Diseases Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Inflammatory Skin Diseases Treatment Market Size Forecast by Type
13.6.1 Retinoids
13.6.2 Corticosteroids
13.6.3 Calcineurin Inhibitors
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Inflammatory Skin Diseases Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Inflammatory Skin Diseases Treatment Market: Competitive Dashboard
14.2 Global Inflammatory Skin Diseases Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Merck
14.3.3 AbbVie
14.3.4 Novartis
14.3.5 Boehringer Ingelheim
14.3.6 Amgen
14.3.7 Eli Lilly
